Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · Real-Time Price · USD
3.955
+0.055 (1.41%)
Oct 1, 2025, 4:00 PM EDT - Market closed
Kezar Life Sciences Market Cap
Kezar Life Sciences has a market cap or net worth of $28.96 million as of October 1, 2025. Its market cap has decreased by -30.36% in one year.
Market Cap
28.96M
Enterprise Value
-59.44M
1-Year Change
-30.36%
Ranking
Category
Stock Price
$3.96
Market Cap Chart
Since June 21, 2018, Kezar Life Sciences's market cap has decreased from $325.21M to $28.96M, a decrease of -91.09%. That is a compound annual growth rate of -28.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 28.56M | -41.75% |
| Dec 31, 2024 | 49.03M | -28.81% |
| Dec 29, 2023 | 68.87M | -85.69% |
| Dec 30, 2022 | 481.38M | -41.42% |
| Dec 31, 2021 | 821.73M | 240.23% |
| Dec 31, 2020 | 241.52M | 214.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 649.67B |
| Johnson & Johnson | 434.71B |
| AbbVie | 391.54B |
| UnitedHealth Group | 311.33B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 230.58B |
| AstraZeneca | 228.75B |